IRWD
Ironwood Pharmaceuticals, Inc. - Class A Common Stock NASDAQ
- Avg call return
- −2.9%
- −5.3% vs. index
- Scored calls
- 2
- Channels
- 1
- Win Rate
- 50%
- Side taken
- 2Buy 0Sell
2 scored calls · 1 channels · first tracked 20 Jul 2026
IRWD: tracked call record. Across the full tracked record, 2 of 2 published calls are scored, with an average call return of -2.89%. Scored calls were published from 20 Jul 2026 to 29 Aug 2026, measured from each entry price to its latest available close (price dates: 08 Oct 2026 to 08 Oct 2026). Average benchmark excess is -5.33 percentage points, based on 2 of the 2 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.
Who is calling IRWD
Last 12 months · 1 buying · 0 selling
-
01
WallStreetZen Buy Calls 2 Return −2.9% Show calls
-
29 Aug 2026
Buy
Entry
$4.13
Now
$3.87
−6.3%
vs. index
−6.9%
AI-extracted call. Cite this call
This pharma stock may be very good medicine for your portfolio.
-
20 Jul 2026
Buy
Entry
$3.85
Now
$3.87
+0.5%
vs. index
−3.8%
AI-extracted call. Cite this call
We have just one analyst with a buy recommendation, but it's worth noting that the price target implies upside potential of more than 130% in the coming year.
-
29 Aug 2026
Buy
Entry
$4.13
Now
$3.87
−6.3%
vs. index
−6.9%
Every video calling IRWD
Understand these figures or report an error: Methodology Corrections policy